Ticker Details
Recursion Pharmaceuticals, Inc.
IPO Date:	April 16, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.74B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 4.31%
Avg Daily Range (30 D):	$0.11 | 3.31%
Avg Daily Range (90 D):	$0.11 | 3.30%

Institutional Daily Volume
Avg Daily Volume:	9.26M
Avg Daily Volume (30 D):	16.66M
Avg Daily Volume (90 D):	17.13M

Trade Size
Avg Trade Size (Sh.):	253
Avg Trade Size (Sh.) (30 D):	399
Avg Trade Size (Sh.) (90 D):	347

Institutional Trades
Total Institutional Trades:	3,013
Avg Institutional Trade:	$2.27M
Avg Institutional Trade (30 D):	$2.08M
Avg Institutional Trade (90 D):	$2.38M
Avg Institutional Trade Volume:	.34M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.93M
Avg Closing Trade (30 D):	$3.04M
Avg Closing Trade (90 D):	$3.9M
Avg Closing Volume:	592.45K

News

Aug 6, 2026 @ 2:52 PM AI Disruption Reshapes Bioinformatics: Record Inve... Source: Bcc Research

Jul 31, 2026 @ 8:30 PM Recursion Reports Grant of Inducement Awards as Pe... Source: Na

Jul 30, 2026 @ 8:30 PM 3 Stocks With the Most Upside by the End of 2026 Source: James Brumley

Jul 11, 2026 @ 8:30 PM 2 Beaten-Down Stocks That Still Aren't Worth Buyin... Source: Prosper Junior Bakiny

Jul 10, 2026 @ 2:55 PM Generative AI in Drug Discovery: Revolutionizing P... Source: Researchandmarkets.Com

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1	$-.25	$-.22
Diluted EPS	$-1	$-.25	$-.22
Revenue	$54.86M	$7.67M	$6.47M
Gross Profit	$1.91M	$-3.82M	$-6.02M
Net Income / Loss	$-518.88M	$-131.01M	$-117.5M
Operating Income / Loss	$-544.01M	$-134.97M	$-128.51M
Cost of Revenue	$52.94M	$11.49M	$12.49M
Net Cash Flow	$22.98M	$-108.36M	$-88.74M
PE Ratio